DatasetName,PPP1R35_S(12) PPP1R35_S(34) PPP1R35_S(52),PPP1R35_S(45) PPP1R35_S(47) PPP1R35_S(59) PPP1R35_S(82) PPP1R35_S(84) PPP1R35_S(87) PPP1R35_T(84) PPP1R35_T(87)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5396100456747445,0.5451781811937755
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.5016963444219669,0.5493222427890057
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,0.4574761426661404,0.5408376576096371
JJ2018_Ratio H/M normalized pP2,0.49746265503732195,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,0.48159986978160974,
DL2023_control-3,,0.5355292453097314
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.5188728993722079,0.5598468054159584
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.4094410741544787,0.5555137061555515
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.4624597097572068,0.5197396487547372
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,0.4802969528243082,
KBE2022_Log2_Ex_44_T,0.4972463055052816,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.502844568073392,0.5398595839621033
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5475858599938556,0.5905526061571252
FSO2013_Ratio M/L normalized Rep1___1,0.4630891803538513,0.5282241977836375
SAS2015_AZD/DMSO_Exp3,0.47860011171366573,0.5375232314783025
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,0.4796626820288515,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5122587734845386,0.5376966344952823
WZ2023_Pu_010_30min,0.5539793696072061,0.6025405470131519
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,0.5039571104959814,
ZQ2022_C2,,
RB2022_5_PreSprint,0.5216335808012794,
PG2020_Intensity 8h_C,0.49458749818771225,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,0.41783231561600837,0.5484852289050342
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,0.48074785609130877,
LY2019_P1+,0.46571930539529455,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.4865365928481776,0.5368910780663823
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.5662552291674142
EP2017_Pervanadate R#3 normalized log2 ratio,0.4535298866463379,0.5165792334888163
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.4901180080317655,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.4927159045037272,
GF2025_P6_Sph,0.4930872479540949,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5548960781293596,0.6037462035729647
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.5048170117842873,0.5408338217809133
KBE2022_Log2_Ex_34_U,0.5023858596184715,
WZ2023_Pu_005_10min,0.5534154638318345,0.6014601025951394
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5536005172597811,0.6006491834563218
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.5347493156181032,0.5989710805878734
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4879238317564762,0.5302758963805184
FR2021_Norm.Intensity.B,0.47509781264444256,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5003619099227402,
EJN2021_3_Rest_Basal,0.47576689901133157,
CR2017_Ratio Replicate 1.3,0.542749352348663,0.5523255954478548
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,0.5323737486218222,0.5378719267022167
FSO2013_Ratio H/L normalized Rep1___1,0.49001234299873303,0.5539428410641428
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.4991369425246195,
HS2024_3_B_N1,0.47836083727851336,0.5471687670736104
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5554384543056372,0.6037998153073034
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,0.5489020146467627
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,0.5169752960074455,0.585634670366673
WZ2023_Pu_005_20min,0.5546859982290407,0.6028771935992641
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5218437606778642,0.5360491276129495
CW2012_10 µM Gef/control Experiment 2 Replicate B,,0.56349593601714
HS2024_7_B_T3,0.4716399478539006,0.5111808081273983
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,0.48104316202872344,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.49647402419213216,0.5494157273346174
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.49206049947163927,0.5223297884071882
FSO2013_Ratio M/L normalized Rep3___2,,0.574040761386418
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5449813399061078,0.5627833920705425
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.5122432819089164,0.5430050046791742
PG2020_Intensity Mock_10h_D,0.5196172777666471,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.4851495129919232,0.5159789420919156
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.49843781401945764,0.5441120509546667
RB2022_6_RecoveryEndurance,0.5002179903353663,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.46036962984416335,0.5420211004247487
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,0.543387676507571
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,0.40646208694261116,0.5583817523760699
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.48721532093269765,0.5755260252126825
CR2017_Ratio Replicate 3.3,0.5121994231602435,0.5550509766355681
PG2020_Intensity 2h_C,0.5142717186089977,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5098757855069519,0.5153242700619404
RN2012_L11,,0.5407350033006602
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,0.5541310245500396
HS2024_5_PD_T1,0.5047458684646179,0.5483926694784218
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5082576921202451,0.5474536368152765
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,0.5424194347257324
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,0.48003532184507386,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,0.4534207472976816,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,0.471509644664144,
HS2024_9_B_T1,0.5264598766090361,0.5499661513506705
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,0.47934802646232866,0.5537732890559285
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.49715841486291,0.5421929522198453
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5230306347670822,0.5786496353156049
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,0.49473576038620654,
CR2017_Ratio Replicate 3,0.4974133966227141,0.5441697412508245
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),0.5495835700673138,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.4799014321618517,
HS2024_8_I_T3,0.5114607032791052,0.5527425235734384
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5123957673048262,0.5322945775867446
DL2023_12h-2,,0.542548179948123
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5534470786256218,0.6022069815754746
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,0.5079426087417679,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,0.4530246196722023,0.5192869604657251
RAM2015_Log2 A,0.46726624699930563,0.5302471245021533
HS2024_8_PD_T1,0.49075531143754353,0.5159555594030321
JJ2018_Ratio H/L normalized pP2,0.48282518895445375,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.512380388705226,
HS2024_7_I_T1,0.47599991233342126,0.5049213954030412
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.5043292633910809,0.5477879324271335
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.4805728805873466,0.5257944037795129
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,0.4818511005279407,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5026093683019484,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.5059155262968543,0.5423775384965425
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5143434650141144,0.5397255318844965
HS2024_6_B_N1,0.502252225919413,0.5563330904699462
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,0.5666087914783152
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,0.4802969528243082,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.472497954869408,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,0.46471090388522995,0.55545996413576
PG2020_Intensity 10h_C,0.457326384324617,
FSO2013_Ratio M/L normalized Rep2,0.47736197498613303,0.5130394902573525
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5510544262119653
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,0.5275535297186168,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.4791154901680286,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5190535942814197,0.5775835610495967
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,0.49353080453060016,
RN2012_H05,0.4915579712834564,
NJH2024_Sub7_HIIT_Mid,0.47633965775352527,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.4588161684090859,
HH2022_Reporter intensity 3,0.49438325048253534,0.5553759039843238
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,0.5306851759768346,0.5713124833650596
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,0.5298155364046983,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,0.5586742084574849,0.5644170999789613
JJ2018_Ratio M/L normalized pP2___1,0.48753139105117455,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.5025333940282567,0.532771657073194
CK2022_12 200-1,0.5020980216367681,0.5316017190777113
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,0.4796028819133489,
HH2022_Reporter intensity 9,,0.5550949551936346
WZ2023_Su_010_20min,0.5545382824705515,0.6020812052659478
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5048789526677517,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,0.474882936572083,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.5139120599065384,0.5404504780177787
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.5076985571990144,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,0.5052360340113096,0.5418504169538652
PG2020_Intensity Mock_10h_A,0.5207051590393484,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.4860867873426216,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,0.4769591144033872,
HS2024_7_I_T3,0.5090598495764845,0.5450567057098805
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5562402877942884,0.5859808637251727
CF2017_EOC 1,,
CK2022_3 200-1,0.5124109269663005,0.5427237857216688
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.49839178234662374,0.5367959976029762
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,0.4773485081274555,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,0.5491380620333578
HS2024_6_PD_T2,0.5081051714448086,0.536085370399143
HS2024_5_B_T1,0.5050947465954162,0.547188989233426
CW2012_10 µM Gef/control Experiment 2 Replicate A,,0.5429682975724612
DL2023_12h-3,,0.5482214999263086
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.527197064091461,0.6002544363142506
RB2022_6_PreStrength,0.4062706665383942,
CK2022_2 40-1,,
RB2022_1_PostSprint,0.46849944778726066,
CK2022_4 200-1,0.5139064461051832,0.543620684665503
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.520353668511675,0.5939408265908998
HS2024_4_B_T1,0.4896067910155364,0.5226728549605172
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.4671134518306828,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5057148850114976,0.5780171031071767
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,0.5138055937964161,
GF2025_P7_Adh,0.5040929969815614,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5141267602655729,0.5405982178657267
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.4707697835720808,0.5370545599162455
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5547248363090147,0.6016789341430284
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5000873509217052,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.5221979006096249,0.5461131015824844
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,0.4367218295708395,0.5504037716461763
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.4832521029398607,0.5478110212305509
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.4896741744781328,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.4846030225881548,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5166263521573643,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,0.48025273946891894,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,0.471509644664144,
HS2024_3_I_T2,0.48311698823884835,0.5180728855949361
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5210072757674039,0.5215303584484484
CW2012_10 µM Erl/control Experiment 2 Replicate B,,0.5831852553819586
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.45950394544947387,0.5263083432103658
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.481090881979039,
HH2022_Reporter intensity 6,,0.5463795085525651
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.4624860624983937,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.533647083792775,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,0.4997166531067389,0.5380411588729356
JAW2011_Ratio H/L LS1a,0.4662620383819876,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,0.47540559142568584,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.47766365763131863,0.5313670471485462
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.5318764704616923,
RB2022_7_RecoverySprint,0.5506815041867905,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.49910582667639464,0.5319755791477776
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.4735090038062389,
HH2022_Reporter intensity 1,0.5002913118021272,0.5558150060784952
HH2022_Reporter intensity 2,,0.5557003407218457
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,0.405897275270273,0.5513725975111335
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,0.4135025831108729,0.5512663245673336
HS2024_8_B_T1,0.4886364420636375,0.5388216178742798
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.4668825733974388,0.5528143378868016
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5347528768042489,0.5618465515606537
CW2012_10 µM Erl/control Experiment 2 Replicate A,,0.5468765140332221
FSO2013_Ratio H/M normalized Rep3,0.5120695176535649,0.5698829004232554
AR2021_KD 72h,0.4772849347206974,0.5417017414720993
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5205363611698186,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,0.474882936572083,
DL2023_24h-2,,0.5442777989451859
HS2024_7_B_N2,0.5245371581970354,0.5716161412731824
PG2020_Intensity 10h_A,0.4898356690993391,
RN2012_L12,,0.5377261532069545
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,0.5173052216902715,0.5594983964287923
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.45717720808518764,0.5264987580334962
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.473669556412819,0.5361158856699997
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,0.5120672415206782,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.48621924519056825,
TM2022_S2.12h.B,,
RN2012_L15,,0.545108294399494
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.48856598424377445,
FSO2013_Ratio H/M normalized Rep2___2,,0.5452764471375166
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.49512832380233335,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5187102850524986,
RB2022_1_PreSprint,0.4792369789413109,
HS2024_4_I_N1,0.508492053150115,0.5598006875118002
CK2022_7 200-1,0.5296701127034191,0.5508508460788555
CK2022_5 200-1,0.5285393944148499,0.5506801340729888
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5173941634028018,0.5865967909431152
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.431624713141784,0.5554035473426224
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.4988126778056911,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,0.4956222892831033,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.45221662336070323,0.5038001991120171
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.3985127143163015,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,0.46444122866145127,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,0.5238305915213007,0.5389238404518766
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.4874697484877399,
NJH2024_Sub7_MICT_Mid,0.48074785609130877,
PG2020_Intensity 6h_B,0.5103636360175977,
FSO2013_Ratio H/L normalized Rep3,0.5253199059611461,0.5817382115123598
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.5154784862370304,0.554377532896352
JJ2018_Ratio M/L normalized,0.48055176242459857,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.49282203307704986,0.5697757239344713
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5000265759729042,0.5206326164456012
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5288933732602411,
WZ2023_Pe_025_20min,0.5558884108707653,0.6040533172548661
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.49965025443838956,0.5459307115830646
AH2018_LFQ_2_N,,
HS2024_4_I_N2,0.5262210882000633,0.5565532770663776
AH2018_TMTMS2_3_N,,
RN2012_H06,,0.5593122563148483
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5569037963121953,0.5924868756464751
WZ2023_Su_005_30min,0.5530577791048968,0.6009320643759598
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.49842122986902143,0.5404239352271085
WZ2023_Su_025_10min,0.5561965249016086,0.603544916875607
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5544875474837431,0.6017981178864886
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.4854192579859311,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,0.5182087156426469,0.5619551381144188
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.44962750317076744,0.5259358394372055
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.542829014384345,
KS2014_Intensity,0.49451958903643584,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.47942055792557975,
LY2019_P7+,0.5218811792752985,
EP2017_Untreated R#1 normalized log2 ratio,0.48051923214409803,0.5504177375530231
RN2012_L10,,0.5548718219865548
PG2020_Intensity 4h_C,0.49927262621063995,
EP2017_Mitotic R#3 normalized log2 ratio,0.46858067237822926,0.5439495785100954
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,0.42440792710874103,0.5515872011547744
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.49774853224706644,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.5187156359735141,0.5698881390855608
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5215796470945199,0.5417202256228294
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.48269393616609646,
HS2024_8_I_T2,0.5053196730446042,0.5245393577226077
KBE2022_Log2_Ex_6_U,0.49611037841808486,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5007246588850586,0.5408669179360669
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5134598865950855,0.5397444362990174
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4602644544509317,0.5420286244949621
GF2025_P9_Sph,0.542381427473357,
CK2022_6 200-1,0.5291032656051585,0.5509108692221029
NJH2024_Sub7_MICT_Post,0.48159986978160974,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.4744107804009934,0.5616297050837775
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5668102497302075,0.615974137645542
SAS2015_AZD/DMSO_Exp1,0.5108688899322259,0.5336487242006129
NJH2024_Sub1_MICT_Mid,0.47540559142568584,
IMM2018_normalised rep. int. CDK5L-3,,0.5550484221694955
HS2024_3_B_T3,0.5196680531438705,0.566045732751352
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.506751550660693,
EP2017_Untreated R#3 normalized log2 ratio,0.5260720137731351,0.5484313625818109
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,0.47803636456895376,
JAW2011_Ratio H/L LS2,0.48028865783814173,0.5533883964762201
CK2022_8 200-1,0.5283362190199873,0.5505496515696633
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.48878566433888054,0.5471083979153909
RB2022_7_PostEndurance,0.46657092809201856,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5262290902794255,
EP2017_Pervanadate R#2 normalized log2 ratio,0.3953320850549276,0.5079234324001969
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5399281772456112,0.5459317229362963
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.5080088151031882,0.54034399516549
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,0.5406077809023103
HS2024_6_B_T2,0.5333168179471232,0.5448921349215077
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,0.5336707854338433
SAS2015_PLX/DMSO_Exp2,0.5216464638583167,0.5345894714760245
EJN2021_1_Ex_Basal,0.46650245834521936,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.5222677584927969,
ZCP2016_Ratio H/L Rep 1,,0.5671017846037854
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.4949879961836119,
EP2017_Untreated R#3 log2 ratio,0.5283950090993629,0.5509681247996883
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5023074044594795,0.5667455346899006
HS2024_8_PD_T2,0.5076827623792783,0.5309387836949002
FS2019_Ctr2,,
RB2022_6_PreEndurance,0.47934507375468965,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5296324140291014,0.5543251015644506
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5019930473094544,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.4751926595931804,0.5430287552431623
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5077688556751951,0.5793396846531569
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5306547561284124,0.5885173421890771
HS2024_3_PD_T3,0.4847160626314211,0.5296773827492827
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.47273349304848217,0.5192543840353842
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,0.4758338341386405,0.5232251616823592
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.5363036722378655
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.49180963240836917,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,0.5428415869762747
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5210843428330716,0.546018264880232
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,0.5426338662839847
HS2024_7_PD_T3,0.5486151452880909,0.5990129021524642
PG2020_Intensity Mock_10h_B,0.5332867444630055,
WZ2023_Su_025_30min,0.5541957210279019,0.6011984064844291
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,0.4960662545139818,0.5291484508770327
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.5026134498616771,
HS2024_8_I_N1,0.5287983159814005,0.5656959216635258
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.5443134542455829
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,0.5034562585653849,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5035364993961051,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.47999598494780127,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,0.5134895180171902,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.48742529203002455,0.4924497482725773
NJH2025_Sub7_HIIT_Mid,0.47633965775352527,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.4682596018439949,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.521693062129007,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.47360543967282537,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,0.47406794629977717,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.517082875956607,0.5768308489013808
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.4977996800829276,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,0.5137253818738404,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4969129873911318,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),0.45911054670011947,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,0.4818511005279407,
FSO2013_Ratio M/L normalized Rep2___2,,0.5153927781198484
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.48868996190745223,
CR2017_Ratio Replicate 2.4,0.5392925432116916,0.5640278987314089
ZQ2022_N1,,
LY2019_P6-,0.5229416358630179,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5580843043137528
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,0.5095124788665978,0.5628826054573054
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.5586520930665256,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,0.47404113980851875,
PG2020_Intensity 4h_B,0.5094254663605753,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.503825865555585,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5006185996148932,0.5500513076422525
WZ2023_Su_025_20min,0.5534300433971645,0.6005058534446948
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,0.5539191469142913
LY2019_P8-,0.5005249935692155,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.501200931246997,0.5482567267959759
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.4854015168304698,0.5506069943747001
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,0.6062399686761945,0.569673872087806
RN2012_H02,,0.548688302618653
PG2020_Intensity 10h_D,0.46792823944133705,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5009845697938832,0.5414100208572581
EJN2021_4_Ex_Ins,0.42695251392335837,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.40858255721224784,
EP2017_Pervanadate R#3 log2 ratio,0.4514448410245026,0.5122860647504928
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.5078929281068355,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,0.5420697872806322
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5121817492867496,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.4946929615494189,
LY2019_P3-,0.49465582604994046,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.44499027523131396,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5556221838509421,0.6034561795214581
HS2024_8_PD_T3,0.46329846480814857,0.5311196526637636
EJN2021_3_Ex_Basal,0.47156252089663897,
AST2020_Control.1,0.5016063412213122,0.5386429877006998
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5194907165601149,0.5240892302083618
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5534821813794601,0.6003310996114883
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.5866033659992126,0.5603427472507932
GF2025_P10_Adh,0.5228751581127614,
RB2022_1_RecoveryStrength,0.503368015877951,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,0.4500918119516725,
HS2024_5_B_N1,0.4955128806842885,0.5295947456973704
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.5209974717795622,0.5586275798960018
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,0.4905854664312792,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.49759624276163555,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,0.5021309804488872,0.549896836719099
KBE2022_Log2_Ex_28_U,0.4985669487741509,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.5146660203919291,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5565772258964977,0.6046028915811861
AST2020_Control.2,0.5034461337742564,0.5411249453894877
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.4318297312466286,0.5379280832819948
HS2024_3_I_T1,0.5009223550831027,0.524534903023505
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,0.5124199261923198,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.5003509414288014,0.555800840309651
HS2024_6_I_T1,0.5003164971572447,0.5128468745370617
HS2024_5_B_T3,0.49022214255701607,0.522283095951759
JJ2018_Ratio H/M normalized pP1___1,0.5326997729008208,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,0.4499493940201948,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,0.4773485081274555,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4813747491108433,0.5513544152138317
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5542353055346035,0.5986257959390326
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,,0.5215205390301719
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.4937496174625287,
CK2022_9 200-1,0.5036090328058097,0.5345782199388709
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5062605132088155,0.5350391902917864
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.45426804088020284,0.5529374275530095
RBK2021_1332T Late,,
LY2019_P1-,0.4539200560143694,
RKK2015_TNF-α/basal.1,0.4757147787687224,0.539793675947663
RKK2015_TNF-α/TNF-α+SC-514,0.4699203460077677,0.5411719796591897
CR2017_Ratio Replicate 2.5,0.549940821363678,0.605982308709864
HS2024_3_I_T3,0.5088764445698089,0.530417828551311
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.47249110448141884,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,0.4796028819133489,
KBE2022_Log2_Ex_39_T,0.4983244187447646,
FSO2013_Ratio H/M normalized Rep3___2,,0.5878883627446364
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.4823819792239586,0.5528968522920548
RKK2015_SC-514/basal,0.4728625251319061,0.5458975383465945
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5565227103581172,0.6044506868938072
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.44208536469919174,0.45673462899772976
KS2014_Intensity N1,0.4688971868567773,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5062965489813546,0.5402388394857236
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.510990788247915,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,0.5266740608992929,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5552669349568822
HS2024_5_B_N2,0.4911154833183427,0.5386977767041679
HS2024_5_I_N1,0.5023472854329568,0.5474406743654255
HS2024_6_I_N1,0.4534167733286112,0.5072730686671949
AR2021_KD 48h,0.47882510068573936,0.5357682638721795
FR2021_Intensity.B,0.47497656506603475,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.4751443704262754,0.5085630061973392
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.5023441155662947,0.5390050958560539
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5538920511107592,0.5985918092223287
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5015145080667721,0.5017778413864239
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.5145240988091807,0.5409604965261078
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5266257550766325,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.49780582429883236,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5107286030614641,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5118438885019407,0.5427929434613538
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),0.5423347658912653,
WZ2023_Su_010_30min,0.5536501763965646,0.6010832145472575
RN2012_H01,,0.5625510480509908
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.46463741000923875,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.4517620102603958,0.5288755218857732
HS2024_8_B_T3,0.48982539046710993,0.5248862538612099
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.503502834424849,
WZ2023_Pe_010_20min,0.5552678567845001,0.6048821774738059
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,
FSO2013_Ratio H/M normalized Rep3___1,0.5122409565527405,0.5510796583810473
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,0.5015416132812023,0.5479777370170336
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,0.5505765727975567
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5005808180528247,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.554930947548828,0.6017005824136157
PG2020_Intensity 6h_C,0.4979458167030811,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.5292953612628618,0.49257971553223273
JJ2018_Ratio M/L normalized pP1___1,0.48841591184883465,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.489249837019722,
FSO2013_Ratio H/L normalized Rep3___2,,0.5895039397438268
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5064815731543449,0.5464501318901892
GF2025_P8_Adh,0.4989499990434101,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5227290169750467,0.5272100796268131
IMM2018_normalised rep. int. CDK5L-1,,0.5541024719478385
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4738499487652305,0.5497792626134989
EJN2021_2_Ex_Basal,0.47220778622150245,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.5356754861967509,0.5929712228981876
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,0.4978791373554734,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.4823388749573428,0.5402383161795494
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),0.4674899334583091,0.5427468494977263
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.49924596908533786,0.5560045077794524
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.4770006751747482,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,0.4884604180613319,0.5195887605467407
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.44180255581866873,0.6198791065777172
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),0.5095783441314392,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5124533264662555,0.5037645692627811
SAS2015_PLX/DMSO_Exp3,0.5158569216549372,0.5389880174666735
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.5554601700711032,0.6026568019799126
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5386057245721015,0.534863719065895
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,0.56826043195084
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,0.5180027952602315,
WZ2023_Pe_010_30min,0.5570515072476315,0.6052283742938446
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.5115724589245777,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,0.48104316202872344,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,0.5332341949457667,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,,
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,0.4889566060143564,
GF2025_P5_Adh,,
RB2022_1_PostStrength,0.4739294338864484,
JAW2011_Ratio H/L LS1b,0.47404113980851875,
FSO2013_Ratio H/L normalized Rep3___1,0.5258609039517075,0.582394662648042
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5246772136741596,0.5534908491823107
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),0.455717356091661,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.4996204524957129,0.5478364671952709
PG2020_Intensity CT_B,0.5302156297699429,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,0.46263340650995427,0.5555686621672584
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.4960679045619225,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.4806084650700584,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,0.5048279237441359,0.5408778265776557
MV2014_Ratio M/L normalized B1___1 (5 min),0.44363178761631145,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.48612460706803057,
FSO2013_Ratio H/M normalized Rep1___2,,0.5122011594987659
HS2024_8_I_T1,0.4857070257370612,0.5347775576925143
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.4727174430199,0.5491066154988896
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,0.5521011028605072
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.4780302331633089,
HS2024_6_I_N2,0.4629437587095789,0.5501694622527424
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.5274092619988126,0.6157548437504754
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,0.44602026100288766,0.5210542873973484
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,0.47803636456895376,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5078072713002836,0.5587034868218073
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,0.4026666218627406,
PG2020_Intensity 6h_A,0.5010521850018718,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.4659951835159357,0.5504022865951448
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.46715976535049314,
HS2024_5_I_N2,0.4962299150018435,0.5622707009115413
SAS2015_PLX/AZD_Exp3,0.5119591535041795,0.5552819803539146
EP2017_Pervanadate R#2 log2 ratio,0.3927400659741828,0.5040768369955094
AS2011_Ratio H/L Normalized RNAi_2_1,,
